Oxidative stress (OS) and hypercholesterolemia have been linked with a heightened risk of cardiovascular disease (CVD). Because of the numerous drawbacks of synthetic antioxidants and cholesterol-lowering drugs, natural antioxidative and hypocholesterolemic agents are of immense importance. This study was designed to determine both the OS-attenuating and cholesterol-lowering capacities of the hot water extract (HWE) and of five solvent-solventpartitioned fractions of Ganoderma lucidum. In vitro antioxidative performance of G. lucidum HWE and fractions was measured through DPPH free radical scavenging, Folin-Ciocalteu assay, lipid peroxidation inhibition, and human low-density lipoprotein (LDL) oxidation inhibition. In vivo antioxidative performance of G. lucidum was assessed by measuring the plasma and liver antioxidative enzymatic activities (catalase, glutathione peroxidase, and superoxide dismutase) in G. lucidum HWE-fed rats. In the CVD tests, the HWE at 200 mg/kg b.w. lowered plasma levels of total cholesterol, triacylglycerol, and LDL cholesterol and increased high-density lipoprotein cholesterol. The current findings indicate the therapeutic potentiality of G. lucidum as an OS-attenuating and hypocholesterolemic agent en route to withstanding CVD complications.
I. INTRODUCTION
Under normal physiological conditions, reactive oxygen species (ROS) and reactive nitrogen species are generated as a part of cellular metabolic, signaling, and defensive actions. 1 Because they are highly reactive, they undergo reactions with other reactive anions and/or cations and turn into neutral molecules, or the bodily systems neutralize, remove, or attenuate them through different mechanisms. 2 Thus, these reactive species have very short half-lives. 2 However, when the level of their generation outnumbers their dismissal through enzymatic or nonenzymatic processes, the state of oxidative stress (OS) emanates. Persistent OS mediates structural and functional alteration of biomolecules (carbohydrates, proteins, lipids, nucleic acids) and poses a threat to normal functioning of the tissues and organs, resulting in numerous pathophysiological consequences such as cardiovascular diseases (CVDs), diabetes, aging, and neurodegenerative diseases such as Alzheimer's disease. 2, 3 Evolutionarily, cells have adapted themselves to cope with the constant exposure to ROS using multiple defense strategies. 4 Cells thwart OS through physical defense involving stabilization of plasma membrane and steric hindrance. The antioxidative enzymatic defense system includes superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), which counterbalance the production of ROS. 2 SOD first converts the superoxide into relatively less harmful hydrogen peroxide; later on, CAT and GPx turn hydrogen peroxide into water. 2, 5 Also, nonenzymatic intracellular antioxidants act directly by scavenging free radicals or by breaking the free radical-generating chain reactions. This type of antioxidant includes glutathione, flavonoids, pyruvate, vitamin C (ascorbic acid), vitamin E (α tocopherol), and carotenoids. 5 Cells synthesize a trivial amount of the direct-acting antioxidants, and most of them must be supplied through the diet for maintenance of normal cellular functioning against OS. 5 Thus, the supply of the exogenous antioxidants (natural or synthetic) seemed promising as a preventive therapeutic stratagem against ROS-mediated pathophysiology. However, both natural and synthetic antioxidants are available; in this regard, the second form of antioxidant causes numerous side effects. [6] [7] [8] [9] Thus, the demand for natural, dietary antioxidants has gained momentum. 5 Hypercholesterolemia refers to the elevated level of cholesterol in the blood. It is a form of hyperlipidemia (elevated lipid level in blood) also ascribed to dyslipidemia. 10 Cholesterol metabolism occurs in the liver. The rate-limiting step of cholesterol biosynthesis is mediated by 3-hydroxy 3-methyl glutaryl coenzyme A (HMG-CoA) reductase (HMGR). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice has suggested lifestyle and dietary modification as the first line of treatment and pharmacological intervention through lipid-lowering drugs as the second line of treatment against hypercholesterolemia.
11 Lifestyle modification involves losing weight, consuming a diet containing less cholesterol and higher unsaturated fatty acids, giving up cigarette smoking and drinking alcohol, increasing intake of unsaturated fatty acids such as docosahexaenoic acid, and engaging in regular physical exercise. [12] [13] [14] However, a combination of both lifestyle modification and pharmacological treatment may be more realistic. 15 Mushrooms are among the earliest natural agents used by humans. [16] [17] [18] The lingzhi or reishi medicinal mushroom, Ganoderma lucidum (W.Curt.:Fr.) P. Karst. (Ganodermataceae, Agaricomycetes), has been highly appreciated due to its numerous medicinal properties. [19] [20] [21] [22] [23] Although different studies have demonstrated the antioxidative and hypocholesterolemic effects of G. lucidum, studies incorporating both aspects are scarce. Thus, in the present study, we sought to determine the in vitro antioxidative performance of the solvent-solvent partitioned fractions and of the hot water extract (HWE) of G. lucidum, followed by an assessment of the HWE's in vivo antioxidative and hypocholesterolemic potentiality.
II. MATERIALS AND METHODS

A. Mushroom Material and Preparation of Solvent-Solvent-Partitioned Fractions and HWE of G. lucidum
Fruiting bodies of G. lucidum were purchased from a mushroom farm in Tanjung Sepat, Selangor, Malaysia. The mushroom was identified and authenticated by experts via DNA sequencing by the University of Malaya Mushroom Research Centre herbarium. A voucher specimen was deposited in the University of Malaya herbarium (KLU-M1233). We prepared the solvent-solvent partitioned fractions and HWE of G. lucidum using methanol:dichloromethane, dichloromethane, hexane, ethyl acetate, and water.
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B. In Vitro Studies
We measured the in vitro antioxidative effects of all the solvent-solvent partitioned fractions and of the HWE of G. lucidum following standard tests. Our in vitro tests included DPPH free-radical scavenging effects, total polyphenol content through the Folin-Ciocalteu assay, lipid peroxidation inhibitory test, and human low-density lipoprotein (LDL) oxidation inhibitory test. [25] [26] [27] [28] The inhibitory effects of the fractions and of the G. lucidum HWE were also tested.
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C. In Vivo Studies
Animals and Maintenance
Sixty Wistar male rats (weight range, 120 ± 5 g) were randomly divided into four groups: 1) control (C), 2) G. lucidum HWE-fed control (CE), 3) hypercholesterolemic (H), and 4) G. lucidum HWE-fed hypercholesterolemic (HE) rats. In vivo antioxidative and hypocholesterolemic studies of each of the four groups were performed. Hypercholesterolemia in the H rats was evoked by adding 1% cholesterol and 1% cholic acid (for intestinal better absorption of cholesterol) to the basal diet. The composition of the basal diet was as follows (in g/100 g): 50 g wheat flour, 19 g wheat bran, 11.25 g rice polishings, 8 g casein, 10 g egg white, 1 g soybean oil, 0.5 g table salt, 0.125 g vitamin mixture, and 0.125 g mineral mixture. Egg white was replaced with 5% dried mushroom powder for diets fed to the mushroom-fed groups (NC + MS and HC + MS). The composition of the vitamin mixture in the diet was as follows (in g/100 g vitamin mixture): 9.5 × 10 
In Vivo Antioxidative, Hypocholesterolemic, and Organ Function Tests
For in vivo antioxidative studies, activity of the plasma and/or liver parameters of antioxidative enzymes CAT, GPx, and SOD of the extract-fed and control animals were measured utilizing commercially available kits (item nos. 707002 for CAT, 703102 for GPx, and 706002 for SOD; Cayman Chemical, Ann Arbor, MI) following the manufacturer's instructions. [30] [31] [32] [33] The atherogenic index of plasma (AIP), the logarithmically transformed ratio of molar concentrations of triglycerides to high-density lipoprotein cholecterol (HDL-C), was also measured. 34 We calculated the ratio of plasma LDL-C to HDL-C for measuring the LDL:HDL ratio. Using commercially available kits (Sigma-Aldrich, St. Louis, MO), the activity of aspartate aminotransferase (AST)/glutamate oxalate transaminase (GOT), alanine aminotransferase (ALT)/glutamate pyruvate transaminase (GPT), bilirubin, creatinine, and urea levels was determined. [35] [36] [37] [38] [39] 
D. Statistical Analyses
All the experiments were conducted in triplicate, and we present data as the mean ± SEM. We used SPSS version 16 software, and we performed analysis of variance followed by post hoc Tukey's honestly significant difference test at the 95% level.
III. RESULTS AND DISCUSSION
A. In Vitro Studies
Among six fractions, the HWE of G. lucidum mostly (55.13%, significant at P ≤ 0.05) scavenged the DPPH free radical (Table 1 ). The HWE of G. lucidum possessed the best reducing capacity; it had the highest content (in milligrams) of gallic acid equivalents per gram of extract (Table 1 ). In the present study, inhibitory performance of the mushroom extracts upon lipid peroxidation of the buffered egg yolk was assessed through the measurement of thiobarbituric acid reactive substances. Lipophilic biocomponents present in the nonpolar hexane may have inhibited lipid peroxidation and LDL oxidation in the present experiment. Compared to others, the hexane and the HWE of G. lucidum showed better inhibitory effects toward HMGR activity ( Table 2 ). The presence of statin in the G. lucidum fractions was not investigated in the present study; thus, we cannot confirm that natural statins were present in the respective fractions. However, ergosterol was present in the hexane fraction, which might be regarded as an inhibitor of HMGR activity.
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B. In Vivo Studies
Compared with the control rats, hypercholesterolemic rats had lower levels of plasma and liver antioxidant enzymatic (CAT, GPX, and SOD) activities (Tables 3 and 4) . Feeding G. lucidum HWE increased enzymatic antioxidative defense of the rats (Tables 3 and 4 ). During 8 weeks of observation, the hypercholesterolemic (H) rats gained the maximum weight, and their rate of weight gain surpassed that of the others (ranging from 140 ± 5 g up to 280 ± 2 g) (Fig. 1) . However, feeding G. lucidum HWE resulted in decreased weight gain in the HE rats as time passed. Feeding a hypercholesterolemic diet to the rats resulted in increased plasma triacylglycerol (TG) levels ( Table 5) . The hypercholesterolemic (H) rats had a 1.58 times higher plasma TG level than the control (C) rats, indicating the increased atherogenic propensity of the H rats. Feeding of G. lucidum HWE lowered the plasma TG level in both the control (15%) and the hypercholesterolemic (13%) groups (Table 5 ). The TG-lowering effect of G. lucidum HWE was statistically significant in each group compared to their respective controls (Table 5) . TG regulates lipoprotein interactions and thus plays an important role in maintaining lipid homeostasis. Its own level also varies depending on the lipoproteins, especially LDL-C. Increased TG levels in the hypercholesterolemic rats (Table 5 ) might be due to the decreased clearance of TG due to lower lipoprotein lipase activity or to increased deposition of LDL-C. Compared with the C rats, the H rats showed 1.5 times increased plasma total cholesterol (TC) levels ( Table 4 ). The G. lucidum HWE treatment lowered the plasma TC level significantly (P ≤ 0.05) in all the rat groups ( Table 5 ). The TC-lowering effect of G. lucidum might be mediated by several mechanisms. Importantly, the ganoderic acids share the structural features of the active site of HMG-CoA and might bind in the active site of HMGR that contributed its competitive inhibition of HMGR and lowered cholesterol biosynthesis. Also, gano-polyphenolics might bind with bile acids and lower solubility of cholesterol in micelles. 44 On the other hand, significantly increased plasma HDL-C level (P ≤ 0.05) in the G. lucidum HWE-fed rats indicates increased clearance of TC from the peripheral tissue to the liver for excretion that points to a CVD-ameliorating effect of G. lucidum HWE. G. lucidum HWE supplementation caused significant lowering effect upon the plasma level of both LDL-C and VLDL-C in all the rat groups (Table 5) . Mechanistically, G. lucidum HWE induced increased LDL receptors in the rat hepatocytes, which might contribute to the LDL-lowering effect that resulted in lowered secretion of LDL in the rat plasma. Considering the AIP, the H rats had higher AIP than the C rats, and G. lucidum HWE treatment decreased AIP (Table 4 ). The increased AIP of the hypercholesterolemic rats observed in the present study ( might have been caused by the increased level of the atherogenic lipoprotein fractions (LDL-C) associated with hyperlipidemia. 45, 46 The LDL/HDL ratio is another indicator of hyperlipidemia that led to physiological complications, including atherosclerosis. 47 A higher HDL level, lower LDL level, and lowered LDL/ HDL ratio were expected for the hyperlipidemia-modulating agents. 47 G. lucidum HWE feeding was able to lower the LDL/HDL ratio in every rat group (Table 5) .
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Feeding G. lucidum HWE at the dosage of 200 mg/kg b.w. did not cause any visible adverse effect or death of the experimental animals. Compared with the control and the G. lucidum HWE-fed rats, the hypercholesterolemic rats were detected with elevated levels of serum AST/GOT, ALT/GPT, and ALP enzymes in the present study (Table 6 ). These are the enzymes of diagnostic importance that increase in the blood, as they leak out of the damaged cell membranes following CVD complications. Thus, cholesterol affected the plasma membrane integrity and permeability of the hypercholesterolemic rats. In a similar fashion, significantly (P ≤ 0.05) increased bilirubin, creatinine, and urea levels in the hypercholesterolemic rats also indicated the cholesterol-mediated perturbed metabolism of the respective animals (Table 6) . Thus, G. lucidum HWE was safe and nontoxic to the experimental animals. 
